About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNANCT03214679

Accessible HCV Care Intervention for People Who Inject Illicit Drugs (PWID)

The proposed study will examine the feasibility, acceptability, safety, effectiveness, and cost of an Accessible Care intervention for engaging people who inject illicit drugs (PWID) in hepatitis C ca...

Lead sponsor: City University of New York, School of Public Health•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Sponsors

Lead Sponsor

City University of New York, School of Public Health

Collaborators

National Development and Research Institutes, Inc.
National Institute on Drug Abuse (NIDA)
Weill Medical College of Cornell University

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•1. 18 years or older,
•2. injected heroin, cocaine, or other drugs in the past 90 days.
•3. test HCV Ab and RNA positive
•4. provide written consent (including consent for researchers to examine their hepatitis C medical records)

Exclusion Criteria

•Persons already in care for hepatitis C, defined as having had at least 2 visits with a hepatitis treatment provider within the past 6 months, will be excluded.
•People with decompensated cirrhosis will be excluded.

Related studies

RECRUITINGPhase 4

Implementing Low-Barrier HCV Treatment in a Jail Setting

NCT06953479 · HEPATITIS C (HCV), Incarceration, and more

Use of a Patient-Centered Electronic App to Increase ED Patient's Knowledge on HCV to Improve the HCV Care Continuum

NCT04162938 · Hepatitis C

Project I Test: Implementing HIV Testing in Opioid Treatment Programs

NCT03135886 · HIV/AIDS, Hepatitis C, and more

Persuasive Health Communication Intervention for HIV/HCV

NCT05968573 · Human Immunodeficiency Virus (HIV), Hepatitis C (HCV)

Proteogenomic Monitoring and Assessment of Liver Transplant Recipients

NCT01644903 · Liver Transplant, Hepatitis C, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 22, 2023Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment167

Start dateJul 2017

Last updatedFeb 22, 2023

Condition

Hepatitis C People Who Inject Drugs PWID HCV Coinfection

Locations shown

Lower East Side Harm Reduction Center

New York, New York

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 22, 2023Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions